Sutro Biopharma Retained Earnings (Accumulated Deficit) 2017-2024 | STRO

Sutro Biopharma retained earnings (accumulated deficit) from 2017 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Sutro Biopharma Retained Earnings (Accumulated Deficit) 2017-2024 | STRO

Sutro Biopharma retained earnings (accumulated deficit) from 2017 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.